Pharmaceutical Strategies Group (PSG) Releases Highly Anticipated 'Trends in Specialty Drug Benefits Report'

eNewsChannels NEWS: -- Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the release of its annual Trends in Specialty Drug Benefits report. Delivering visibility into the complexity of the specialty drug landscape, it offers detailed intelligence through proprietary research. PSG has been researching and reporting on drug benefit design for over 10 years. :: News from eNewsChannels

Related Keywords

Texas ,United States ,Dallas ,Renee Rayburg ,Morgan Lee ,Michael Lonergan ,Strategies Group ,Pharmaceutical Strategies Group ,Specialty Drug Benefits ,Senior Director ,Vice President ,Gene Therapies ,Alternative Funding ,Value Based Contracting ,Specialty Rebates ,Specialty Drug Benefits Report ,